Increased cardiac contractility during fight-or-flight response is caused by β-adrenergic augmentation of Ca~V~1.2 channels ^[@R1]-[@R4]^. In transgenic murine hearts expressing fully PKA phosphorylation-site-deficient mutant Ca~V~1.2 α~1C~ and β subunits, this regulation persists, implying involvement of extra-channel factors. Here, we identify the mechanism by which β-adrenergic agonists stimulate voltage-gated Ca^2+^ channels. We expressed α~1C~ or β~2B~ subunits conjugated to ascorbate-peroxidase ^[@R5]^ in mouse hearts and used multiplexed, quantitative proteomics ^[@R6],[@R7]^ to track hundreds of proteins in proximity of Ca~V~1.2. We observed that the Ca^2+^ channel inhibitor Rad ^[@R8],[@R9]^, a monomeric G-protein, is enriched in the Ca~V~1.2 micro-environment but is depleted during β-adrenergic stimulation. PKA-catalyzed phosphorylation of specific Ser residues on Rad decreases its affinity for auxiliary β-subunits and relieves constitutive inhibition of Ca~V~1.2 observed as an increase in channel open probability. Expression of Rad or Rem, a homolog, also imparted PKA-induced stimulation of Ca~V~1.3 and Ca~V~2.2, revealing an evolutionarily conserved mechanism that confers adrenergic-modulation upon voltage-gated Ca^2+^ channels.

The positive inotropic effect of β-adrenergic agonists on the heart is a classical physiological phenomenon universally experienced during excitement, exercise, and fight-or-flight. The effect is mediated by β-adrenergic activation of protein kinase A (PKA) which leads to increased Ca^2+^ influx through L-type Ca~V~1.2 channels in cardiomyocytes ^[@R1]-[@R4]^. The commonly accepted model is that PKA increases Ca~V~1.2 current by phosphorylating Ca~V~1.2 α~1C~- and/or β~2B~-subunits ([Fig. 1a](#F1){ref-type="fig"}). However, previously proposed putative regulatory residues on the C-termini of α~1C~ (Ser^1928^; Ser/Thr^1700/1704^) ^[@R10],[@R11]^ and β~2B~ (Ser^512^ and Ser^570^) ^[@R12]^ were shown to be dispensable for β-adrenergic stimulation of Ca^2+^ currents in the heart ^[@R13]-[@R16]^. Nevertheless, given multiple other Ser/Thr residues on α~1C~ and β~2B~, it remained possible that PKA phosphorylation of some combination of these was responsible for β-adrenergic modulation of Ca~V~1.2 in cardiomyocytes. As shown next, this also is not the case.

Core Ca~V~1.2 channel subunit phosphorylation is not required for adrenergic regulation {#S1}
=======================================================================================

We developed a transgenic approach that enables doxycycline-inducible expression of FLAG- tagged, dihydropyridine (DHP)-resistant Ca~V~1.2 channels in mice ([Fig. 1b](#F1){ref-type="fig"}) ^[@R16]^. The transgenic and endogenous Ca~V~1.2 currents are distinguishable by application of nisoldipine, a Ca^2+^-channel DHP-antagonist ^[@R16]^. We mutated all 51 of both conserved and non-conserved Ser and Thr residues within the 35 intracellular PKA consensus phosphorylation sites of rabbit α~1C~ to Ala ("35-mutant α~1C~"; [Extended Data Fig. 1a](#F5){ref-type="fig"}). In cardiomyocytes, the nisoldipine-insensitive 35-mutant Ca^2+^ currents were both up-regulated and activated at more negative potentials in response to isoproterenol or forskolin, to the same extent as were the pseudo-WT (pWT) α~1C~ channels ([Fig. 1c](#F1){ref-type="fig"}-[d](#F1){ref-type="fig"}; [Extended Data Fig. 1b](#F5){ref-type="fig"}-[c](#F5){ref-type="fig"}).

Similarly, we mutated to Ala all 37 conserved and non-conserved Ser and Thr residues within 28 PKA-consensus phosphorylation sites of human β~2B~ ("28-mutant β~2B~"; [Extended Data Fig. 1d](#F5){ref-type="fig"}). Cardiomyocytes expressing GFP-tagged 28-mutant β~2B~ ([Extended Data Fig. 1e](#F5){ref-type="fig"}-[f](#F5){ref-type="fig"}) displayed isoproterenol or forskolin-induced stimulation of Ca~V~1.2 current amplitude ([Fig. 1e](#F5){ref-type="fig"}, [g](#F5){ref-type="fig"}), and a hyperpolarizing shift in the voltage-dependence of activation ([Extended Data Fig. 1b](#F5){ref-type="fig"}), similar to cardiomyocytes isolated from transgenic mice expressing GFP-tagged WT β~2B~ ^[@R17]^.

Finally, we crossed 35-mutant α~1C~ with 28-mutant β~2B~ transgenic mice. Anti-FLAG antibody immunoprecipitation indicated GFP-tagged 28-mutant β~2B~ subunits dominate in the 35-mutant α~1C~ complex ([Extended Data Fig. 1g](#F5){ref-type="fig"}) in cardiomyocytes isolated from these mice. These mutant channels also displayed a normal isoproterenol- or forskolin-induced increase in peak Ca^2+^ current ([Fig. 1f](#F1){ref-type="fig"}-[g](#F1){ref-type="fig"}) and a hyperpolarizing shift in the V~50~ of activation ([Extended Data Fig. 1b](#F5){ref-type="fig"}). These results indicate that β-adrenergic stimulation of Ca~V~1.2 does not involve direct phosphorylation of α~1C~ or β~2~ subunits.

Identifying the Ca~V~1.2 proteome subdomain {#S2}
===========================================

Given the foregoing results, we adapted for application to cardiomyocytes an enzyme-catalyzed proximity labeling method ^[@R5],[@R6]^ to comprehensively identify components of the Ca~V~1.2 macromolecular complex. We generated transgenic mice with doxycycline-inducible, cardiomyocyte-specific expression of DHP-resistant-α~1C~ or β~2B~ proteins with ascorbate-peroxidase (APEX2) and a V5 epitope conjugated to the N-termini, enabling biotin-labeling of proteins within \~20 nm ^[@R18]^ of the Ca^2+^ channels. Fusing APEX2 to α~1C~ and β~2B~ did not affect Ca~V~1.2 subcellular localization and function in cardiomyocytes assessed using cellular electrophysiology, fractional shortening and immunofluorescence ([Extended Data Fig. 2a](#F6){ref-type="fig"}-[d](#F6){ref-type="fig"}). Incubating isolated ventricular cardiomyocytes or perfusing whole hearts with a solution containing biotin-phenol followed by exposure to H~2~O~2~ induced robust biotinylation of proteins in a striated z-disk pattern coinciding with the pattern of transgenic α~1C~ and β~2B~ subunits ([Fig. 2a](#F2){ref-type="fig"}-[b](#F2){ref-type="fig"}; [Extended Data Fig. 2d](#F6){ref-type="fig"}-[e](#F6){ref-type="fig"}).

Western blots confirmed biotinylation of proteins known to be localized near Ca~V~1.2 at dyadic junctions in cardiomyocytes ([Fig. 2c](#F2){ref-type="fig"}). By contrast, K~V~1.5 channels were not biotinylated and enriched ([Fig. 2c](#F2){ref-type="fig"}), implying that these channels may not be as closely localized to Ca~V~1.2. Triple-stage mass spectrometry (TMT SPS MS^3^) identified and quantified hundreds of other biotinylated proteins ([Supplementary Data Table 1](#SD2){ref-type="supplementary-material"}), although many likely constitute bystanders rather than physically interacting proteins. Of these, the 150 proteins with the highest peptide-counts were remarkably similar for α~1C~-APEX2 and β~2B~-APEX2 transgenic mice ([Extended Data Fig. 3a](#F7){ref-type="fig"}). These were primarily classified as being membrane, cytoskeletal, and sarcomeric proteins ([Extended Data Fig. 3b](#F7){ref-type="fig"}-[c](#F7){ref-type="fig"}, [Supplementary Data Table 2](#SD3){ref-type="supplementary-material"}). Some of these proteins, however, were associated with other compartments likely reflecting the labeling of proteins encountered during Ca~V~1.2-APEX2 synthesis, maturation, and trafficking.

Isoproterenol-induced changes in Ca~V~1.2 neighbors {#S3}
===================================================

It seemed likely that PKA-dependent stimulation of Ca^2+^ current in the heart involves recruitment of a distinct activator protein to, or loss of an inhibitory protein from, the Ca~V~1.2 macromolecular complex. Recently, APEX2-labeling, combined with either multiplexed quantitative mass spectrometry ^[@R7]^ or quantitative proteomics using a system of spatial references and bystander ratio calculations ^[@R19]^, was utilized to analyze ligand-induced changes in the local environment of G-protein-coupled receptors. Importantly, conjugation of the peroxidase to either of the Ca~V~1.2 subunits did not interfere with β-adrenergic stimulation of Ca^2+^ currents ([Extended Data Fig. 2f](#F6){ref-type="fig"}-[g](#F6){ref-type="fig"}), and the β-adrenergic agonist signaling pathways were preserved in the presence of biotin-phenol and during H~2~O~2~-induced labeling, assessed by phospholamban phosphorylation ([Extended Data Fig. 2h](#F6){ref-type="fig"}-[k](#F6){ref-type="fig"}).

Isolated cardiomyocytes from α~1C~-APEX2 and β~2B~-APEX2 mice were pre-incubated with biotin-phenol for 30-minutes, and during the final 10-minutes, also exposed to either isoproterenol or vehicle ([Fig. 2d](#F2){ref-type="fig"}). Biotinylated proteins were purified and quantified using TMT SPS MS^3^. Relative summed peptide TMT signal-to-noise, indicating relative protein quantification, changed for several proteins ([Fig. 2e](#F2){ref-type="fig"}-[f](#F2){ref-type="fig"}). We also probed the effect of isoproterenol on the Ca~V~1.2 proteome signature in Langendorff-perfused whole hearts ([Fig. 2g](#F2){ref-type="fig"}-[h](#F2){ref-type="fig"}). Isoproterenol-induced recruitment of the PKA catalytic subunit (PKA~cat~) to Ca~V~1.2 channels was detected in cardiomyocytes isolated from both α~1C~-APEX2 and β~2B~-APEX2 mice ([Fig. 2e](#F2){ref-type="fig"}-[f](#F2){ref-type="fig"}). All three approaches (isolated cardiomyocytes from α~1C~-APEX2 and β~2B~-APEX2 mice, and α~1C~-APEX2 whole hearts) indicated a 30-50% decrease in the amount of the small Ras-like G-protein, Rad, following application of isoproterenol ([Fig. 2e](#F2){ref-type="fig"}-[f](#F2){ref-type="fig"},[h](#F2){ref-type="fig"}, [Extended Data Figs. 4a](#F8){ref-type="fig"}-[c](#F8){ref-type="fig"}, [5a](#F9){ref-type="fig"}-[b](#F9){ref-type="fig"}, [Supplementary Data Tables 3](#SD4){ref-type="supplementary-material"}-[5](#SD6){ref-type="supplementary-material"}). Analyzing the overlap of proteins displaying isoproterenol-induced changes in α~1C~-APEX2 and β~2B~-APEX2 experiments, Rad was the only candidate protein displaying this behavior ([Extended Data Fig. 5b](#F9){ref-type="fig"}-[c](#F9){ref-type="fig"}). In contrast, a 10-minute exposure of cardiomyocytes isolated from non-transgenic mice to isoproterenol ([Fig. 2i](#F2){ref-type="fig"}) had a minimal effect on proteins relatively quantified by TMT SPS MS^3^ and specifically no significant effect on the amount of Rad as compared to non-treated paired cardiomyocytes ([Fig. 2j](#F2){ref-type="fig"}, [Extended Data Fig. 4d](#F8){ref-type="fig"}, [Supplementary Data Table 6](#SD7){ref-type="supplementary-material"}). In this control experiment, proteins were not proximity labeled. Thus, β-adrenergic stimulation depletes Rad from the neighborhood of Ca~V~1.2, but not from the cell as a whole.

Rad is a member of the Rad, Rem, Rem2, and Gem/Kir (RGK) family of Ras-like GTP-binding proteins, known for their capacity to inhibit all high-voltage-activated Ca^2+^ channels ^[@R8],[@R9]^, and is a potential PKA target ^[@R20]^. Moreover, Rad-knockout mice display an increased basal Ca^2+^ current and the Ca^2+^ channels activate at lower voltages, mimicking the effects of β-adrenergic receptor stimulation ^[@R21],[@R22]^. Other studies, however, led to expectations that Rad is not directly involved in adrenergic regulation of Ca~V~1.2 since over-expression of Rad ^[@R23]^ or Rem ^[@R24]^ in cultured cardiomyocytes markedly attenuated basal Ca~V~1.2 current that was not rescued by β-adrenergic stimulation. Nevertheless, our proximity labeling results elevated Rad as the leading candidate for the critical missing link that enables PKA regulation of Ca~V~1.2.

PKA regulation of Ca~V~1.2 requires phosphorylation of Rad {#S4}
==========================================================

The robust heterologous reconstitution of PKA regulation of Ca~V~1.2 currents has been long pursued as a crucial step in identifying and validating the mechanism. We now find that Rad was the missing ingredient. To prove this experimentally, we co-expressed Rad with α~1C~ and β~2B~ subunits in HEK293T cells, limiting Rad expression by using 1:3 to 1:6 cDNA ratio of Rad:Ca~V~1.2 subunits in order to avoid eliminating the Ca^2+^ current. Perforated, whole-cell patch clamp was used to preserve the normal intracellular milieu and signaling cascades, and minimize current run-down. In HEK293T cells transfected with only α~1C~ + β~2B~, superfusion of forskolin over 1-3 minutes had no impact on Ba^2+^ current ([Fig. 3a](#F3){ref-type="fig"}-[b](#F3){ref-type="fig"}, [g](#F3){ref-type="fig"}-[h](#F3){ref-type="fig"}). In contrast, applying forskolin to cells expressing α~1C~ + β~2B~ + Rad increased the maximal conductance (G~max~) by as much as 4.5-fold and by a mean of 1.5-fold, and shifted the V~50~ for activation ([Fig. 3c](#F3){ref-type="fig"}-[d](#F3){ref-type="fig"}, [g](#F3){ref-type="fig"}-[h](#F3){ref-type="fig"}; [Extended Data Fig. 6a](#F10){ref-type="fig"}-[b](#F10){ref-type="fig"}). The forskolin-induced increase in current was inversely proportional to the basal current density, as observed in cardiomyocytes ([Extended Data Figs. 1c](#F5){ref-type="fig"}, [6c](#F10){ref-type="fig"}). In HEK293T cells expressing 35-mutant α~1C~ + 28-mutant β~2B~ + Rad, applying forskolin increased G~max~ by as much as 3.1-fold and by a mean of 1.9-fold, and caused a hyperpolarizing shift in the V~50~ for activation ([Fig. 3i](#F3){ref-type="fig"}, [Extended Data Fig. 6d](#F10){ref-type="fig"}-[e](#F10){ref-type="fig"}). For both WT and phospho-site mutant α~1C~ and β~2B~ subunits, the forskolin-induced enhancement of Ba^2+^ current in Rad-transfected cells was greatest at hyperpolarized potentials and fell as the test potential approached the reversal potential ([Extended Data Fig. 6f](#F10){ref-type="fig"}-[g](#F10){ref-type="fig"}), consistent with observations in cardiomyocytes ^[@R25]^.

We used single-channel recordings to determine the mechanism of PKA/Rad modulation of Ca~V~1.2. In the absence of Rad, sweeps with no openings or blank sweeps are rare, while most sweeps exhibit either intermediate or high levels of openings ([Fig. 3j](#F3){ref-type="fig"}, [Extended Data Fig. 6h](#F10){ref-type="fig"}, [k](#F10){ref-type="fig"}). In HEK293T cells transfected with α~1C~ + β~2B~, co-expression of PKA~cat~ subunit had no effect on open probability (P~O~) ([Fig. 3j](#F3){ref-type="fig"}). When Rad is expressed, the fraction of blank sweeps is increased, low activity mode predominates, and the P~O~ is reduced ([Fig. 3k](#F3){ref-type="fig"}, [Extended Data Fig. 6i](#F10){ref-type="fig"}). By comparison, if the PKA~cat~ subunit is co-expressed with Rad, the fraction of blank sweeps is reduced, the high activity mode resurges, and P~O~ is increased by 10.6 ± 2.9-fold compared to transfection without PKA ([Fig. 3k](#F3){ref-type="fig"}, [Extended Data Fig. 6j](#F10){ref-type="fig"}, [l](#F10){ref-type="fig"}). These results suggest that Rad potently dampens Ca~V~1.2 current while phosphorylation of Rad allows channels to operate as though they were devoid of Rad.

We identified 14 consensus PKA phosphorylation sites in Rad ([Extended Data Fig. 7a](#F11){ref-type="fig"}), which were mutated to Ala. This mutant Rad effectively inhibited Ca~V~1.2 currents; however, the cAMP-PKA mediated upregulation of Ca~V~1.2 current was lost ([Fig. 3g](#F3){ref-type="fig"}). In lysates from forskolin-stimulated HEK293T cells transfected with GFP-Rad, we observed phosphorylation of Ser^25^, Ser^38^ and Ser^300^ by mass spectrometry ([Extended Data Fig. 7b](#F11){ref-type="fig"}). These residues were previously identified in the hearts of mice as phosphorylation targets ^[@R26]^ ([Extended Data Fig. 7c](#F11){ref-type="fig"}). We were unable to detect either non-phosphorylated or phosphorylated peptides containing Ser^272^, notwithstanding prior biochemical studies identifying Ser^272^ as a PKA target ^[@R20]^. Alanine-substitutions of Rad at Ser^25^, Ser^38^, Ser^272^ and Ser^300^ (4-SA mutant, [Extended Data Fig. 7d](#F11){ref-type="fig"}) prevented the forskolin-induced increase in G~max~ and hyperpolarizing shift in the I-V curve ([Fig. 3e](#F3){ref-type="fig"}, [g](#F3){ref-type="fig"}-[h](#F3){ref-type="fig"}). In contrast to transfection with WT Rad, co-transfection of PKA with 4-SA mutant Rad failed to increase P~O~ (PKA to no PKA: 1.15 ± 0.56-fold; [Fig. 3l](#F3){ref-type="fig"}).

A C-terminal polybasic region of 32 amino acids in Rad is involved in plasma membrane targeting via binding to negatively charged phospholipids such as phosphatidylinositol 4,5-bisphosphate (PI(4,5)P~2~ or PIP2) ^[@R27]^. Deletion of the C-terminus of RGK GTPases prevents their inhibition of Ca^2+^ channel function ^[@R9]^. We found that Ala-substitutions at Ser^272^ and Ser^300^ (2-SA mutant) within the C-terminal polybasic membrane region prevented both the forskolin-induced increase in current amplitude and the hyperpolarizing shift in the I-V curve ([Fig. 3f](#F3){ref-type="fig"}-[h](#F3){ref-type="fig"}; [Extended Data Fig. 6c](#F10){ref-type="fig"}).

Rad binding to β is required for PKA regulation of Ca~V~1.2 channels {#S5}
====================================================================

Rad can inhibit Ca~V~1.2 via β-dependent and β-independent (α~1C~-dependent) mechanisms ^[@R28]^. Either Ala-substitutions of Rad at residues R208 and L235, or Ala-substitutions at residues D244, D320 and D322 of β~2B~ ([Extended Data Fig. 8a](#F12){ref-type="fig"}-[b](#F12){ref-type="fig"}) attenuate Rad binding to β subunits ^[@R28],[@R29]^. These mutations prevented the forskolin-induced increase in G~max~ and the hyperpolarizing shift in the I-V curve ([Fig. 4a](#F4){ref-type="fig"}; [Extended Data 8c](#F12){ref-type="fig"}-[d](#F12){ref-type="fig"}). Thus, the Rad-β subunit interaction is essential for cAMP-PKA regulation of Ca~V~1.2.

We utilized flow-cytometry Förster resonance energy transfer (FRET) 2-hybrid assay ^[@R30]^ to probe potential PKA-mediated changes in the binding of β~2B~ subunit and WT Rad. At baseline, robust binding is detected between Cerulean-tagged β~2B~ subunit and Venus-tagged WT Rad, consistent with previous studies ^[@R31]^ (K~d,EFF~ = 7957 ± 418; [Fig. 4b](#F4){ref-type="fig"}, [Extended Data Fig. 9c](#F13){ref-type="fig"}). Co-expression of PKA~cat~ subunit, however, markedly weakened this interaction (K~d,EFF~ = 145231 ± 3084). In contrast, co-expression of the PKA~cat~ subunit in cells expressing fluorophore-tagged β~2B~ and 4-SA mutant Rad had no effect on FRET binding (K~d,EFF~ = 4349 ± 138 versus K~d,EFF~ = 4346± 197 with and without PKA catalytic domain respectively; [Fig. 4c](#F4){ref-type="fig"}, [Extended Data Fig. 9c](#F13){ref-type="fig"}). These results suggest that phosphorylation of Rad is required for dissociation of the Rad-β~2B~ interaction. In a similar manner, PKA phosphorylation of Rad also reduced FRET binding to both β~3~ and β~4~ ([Extended Data Fig. 9a](#F13){ref-type="fig"}-[c](#F13){ref-type="fig"}).

Rad and Rem confer PKA regulation to Ca~V~1.3 and Ca~V~2.2 channels {#S6}
===================================================================

In adrenal chromaffin cells and the sinus node cells of the heart, L-type Ca~V~1.3 channels are robustly stimulated by PKA ^[@R32],[@R33]^. In HEK293T cells transfected with only Ca~V~1.3 α~1D~ + β~2B~, superfusion of forskolin over 1-3 minutes had no impact on Ba^2+^ current ([Fig. 4d](#F4){ref-type="fig"}-[f](#F4){ref-type="fig"}). In contrast, in cells expressing α~1D~ + β~2B~ + Rad, applying forskolin increased G~max~ by as much as 2.3-fold and by a mean of 1.9-fold, and shifted the V~50~ for activation ([Fig. 4d](#F4){ref-type="fig"}-[f](#F4){ref-type="fig"}). We also expressed the N-type Ca~V~2.2 α~1B~ subunit, which is widely expressed in neurons, with β~2B~ and Rad in HEK293T cells. Forskolin increased G~max~ through Ca~V~2.2 when co-expressed with Rad by a mean of 2.2-fold and shifted the V~50~ for activation ([Fig. 4g](#F4){ref-type="fig"}-[i](#F4){ref-type="fig"}). For both Ca~V~1.3 and Ca~V~2.2, attenuating binding of Rad to β prevented the forskolin-induced modulation of Ca~V~2.2 current ([Extended Data Fig. 8e](#F12){ref-type="fig"}-[f](#F12){ref-type="fig"}). We also expressed in HEK293T cells the Ca~V~2.2 α~1B~ subunit with β~2B~ and Rem, another member of the RGK GTPase family. Forskolin increased G~max~ through Ca~V~2.2 when co-expressed with Rem by 1.6-fold and shifted the V~50~ for activation ([Fig. 4g](#F4){ref-type="fig"}-[i](#F4){ref-type="fig"}). Thus, PKA-modulation of Ca~V~ channels is not idiosyncratic as currently believed; rather, it is emerging to be a universal mechanism transferable to all Ca~V~ channels that bind β subunits.

Discussion {#S7}
==========

The core α~1C~ and β~2B~ subunits, previously hypothesized to contain the PKA target sites required for β-adrenergic agonist-induced stimulation of Ca~V~1.2, do not. Rather, successful reconstitution of regulation in a heterologous expression system required an additional component, which we now identify as Rad. The cAMP-PKA regulation on Ca~V~1.2 required both the phosphorylation by PKA on the C-terminus of Rad and the interaction of Rad with the β subunit. Multiple-alignment analysis of mouse Rad and other species shows conservation of the four phosphorylation sites ([Extended Data Fig. 10a](#F14){ref-type="fig"}). The required interaction with the β subunit is consistent with our recent findings showing that disrupting the α~1C~-β interaction prevented PKA regulation of Ca~V~1.2 in heart ^[@R17]^.

Analysis of Rad and other members of the RGK GTPase family indicate that their C-terminal phosphorylation sites are highly similar ([Extended Data Fig. 10b](#F14){ref-type="fig"}). Short stretches of basic and hydrophobic amino acids are known to interact with the membrane ^[@R27]^ and phosphorylation of residues within these stretches alters their electrostatic character, thereby reducing membrane affinity. ^[@R34]^ We found that phosphorylation of two Ser residues within the C-terminal polybasic region of Rad released the Ca^2+^ channels from Rad-mediated inhibition, likely mediated by reducing the affinity of Rad with the membrane and the Ca~V~β-subunit ([Fig. 4j](#F4){ref-type="fig"}-[k](#F4){ref-type="fig"}). This mechanism of regulation is modular and transferable as Ca~V~1.3 channels and neuronal Ca~V~2.2 channels are also imparted with forskolin-PKA mediated upregulation by Rad and Rem. The activation of Ca^2+^ channels via release of inhibition by PKA phosphorylation is reminiscent of PKA phosphorylation of phospholamban, an inhibitor of SERCA ^[@R35]^.

Whereas phosphorylation of Ser^1928^ is definitively not required for β-adrenergic regulation of Ca~V~1.2 in the heart, Ala-substitution of Ser^1928^ prevents β-adrenergic stimulation of Ca^2+^ channels in hippocampal neurons and hyperglycemia-induced stimulation of Ca^2+^ currents in arterial smooth muscle cells ^[@R36],[@R37]^. Perhaps, there are tissue-specific differences in Ca~V~1.2 regulation. Phosphorylation on the α~1C~ subunit may also affect the trafficking and channel clustering in neurons and cardiomyocytes ^[@R38],[@R39]^.

Our results indicate that proximity labeling using APEX2 is feasible in heart and combined with multiplexed TMT proteomics can identify a dynamically evolving network of interactions induced by β-adrenergic stimulation. This study establishes the utility of proximity labeling in animals and provides an important foundation for future studies that will investigate how diseases, such as heart failure, change the proteomic subdomain of the excitation-contraction coupling machinery.

Augmented Ca^2+^ entry loads the cardiomyocyte with additional Ca^2+^ and enhances RyR opening via Ca^2+^-induced Ca^2+^ release. This increases cardiac contractility. Dysregulation of Ca~V~1.2 activity can result in cardiac arrhythmias, heart failure and sudden death. Supporting an important role of RGK GTPases in humans, a Rem2 variant was identified as a genetic modifier in long QT syndrome 2 ^[@R40]^, and a Rad variant was recently linked to Brugada syndrome ^[@R41]^. Our results identify potential targets and interaction sites for the therapeutic modulation of β-adrenergic regulation of Ca^2+^ currents in the heart and other tissues. For instance, disrupting the interaction between Rad and β subunit can be inotropic by increasing Ca^2+^ entry in the heart. Conversely, interfering with the α~1C~-β interaction ^[@R17]^, blocking PKA phosphorylation of Rad or potentially enhancing the interaction of Rad with the plasma membrane could attenuate the sympathetic nervous system activation of cardiac Ca^2+^ entry and inotropy more specifically than achievable with β-blockers.

Methods: {#S8}
========

Clone construction and cell culture. {#S9}
------------------------------------

All mouse N-terminal-GFP-tagged mouse Rad (accession \# XM_006531206) constructs in a pEGFP-C1 vector were generated by gene-synthesis (Gene Universal). The human Ca~V~2.2 (pSAD442-1) was a gift from Diane Lipscombe (Addgene plasmid \# 62574; <http://n2t.net/addgene:62574> ; RRID:Addgene_62574). All cDNA clones were authenticated by sequencing.

HEK293T cells (ATCC, CRL-3216) were cultured in DMEM with 10% FBS, 1% Pen/Strep, and transfected with 3 μg rabbit α~1C~ (accession \# X15539) or human α~1B~ (for Ca~V~2.2 experiments) or rat α~1D~ (for Ca~V~1.3 experiments, accession \# AF3070009), 3 μg human β~2B~ (NM-201590.3) and 0.5 μg N-terminal-GFP-tagged mouse Rad using Lipofectamine 2000 (Thermo Fisher Scientific). The media was changed 4-6 hours after transfection. The cells were split onto coverslips coated with attachment factor protein (Gibco). Electrophysiological recordings were carried out at room temperature 24-48 hours after transfection. The cells were authenticated by ATCC and tested for mycoplasma contamination.

Transgenic mice generation: {#S10}
---------------------------

The Institutional Animal Care and Use Committee at Columbia University approved all animal experiments. Male and female mixed-strain mice, 6-weeks to 4-months of age were used. Sample sizes exceeded the number of samples determined by power calculations, which were based on effect sizes previously reported ^[@R16],[@R17],[@R42],[@R43]^. Number of animals was always greater than 3 per genotype. The investigators were blinded to group allocation during data acquisition and analysis.

The transgenic constructs were generated by fusing rabbit α~1C~ cDNA or human β~2B~ cDNA to the modified murine α-myosin heavy chain (MHC) tetracycline-inducible promoter vector (gift of Jeffrey Robbins and Jeffrey Molkentin, University of Cincinnati, Cincinnati, OH) ^[@R44],[@R45]^. A 3X FLAG-epitope was ligated in-frame to the N-terminus of α~1C~. The α~1C~ subunit was engineered to be dihydropyridine (DHP)-insensitive with the substitutions T1066Y and Q1070M ^[@R46],[@R47]^. GFP was ligated to the N-terminus of β~2B~. The creation of GFP-WT β~2B~ transgenic mice was described previously ^[@R17]^. The V5 epitope and APEX2 cDNA ^[@R5],[@R48]^, created by gene synthesis, were conjugated to the N-terminus of DHP-resistant-α~1C~ and WT β~2B~.

The 35-α mutant and the 28-β mutant cDNA were generated by site-directed mutagenesis. The optimal PKA phosphorylation motif is a tetrapeptide with Arg at the 2nd and 3rd positions (termed −2 and −3) prior to the phosphorylated Ser or Thr, and a large hydrophobic residue immediately thereafter (R-R-X-S/T-Φ) ^[@R49]-[@R51]^. The requirement for a positive charge is highest for residues at -2 and -3, but can be found for residues as far as position -6 in PKA target sites ^[@R52]^. Sites with Arg in positions between −4 and −1 are strongly preferred and to a lesser extent His or Lys ^[@R50],[@R53]^. We identified all potential intracellular PKA phosphorylation sites ([Extended Data Fig. 1a](#F5){ref-type="fig"}, [d](#F5){ref-type="fig"}) in rabbit α~1C~ and human β~2B~ using both manual sequence analysis and several web-based PKA phosphorylation prediction tools, including pKaPS ^[@R54]^, DISPHOS ^[@R55]^, GPS ^[@R56]^, NETPHOS ^[@R57]^ and SCANSITE ^[@R58]^. Each phosphorylation site was mutated to Ala. We also mutated additional Ser and Thr within several amino acid residues C-terminal to the Arg or Lys, in order to ensure that we fully captured each phospho-regulatory site. 51 residues in rabbit α~1C~ were replaced with Ala at 35 potential phospho-regulatory domains in the 35-mutant α~1C~ construct, and 37 residues were replaced with Ala at 28 putative phospho-regulatory domains of β~2B~. We excluded those sites predicted to be extracellular or within the plasma membrane.

Transgenic mice with non-targeted insertion of these tetracycline-regulated cDNA ([Fig. 1b](#F1){ref-type="fig"}) were bred with cardiac-specific (α-MHC), doxycycline-regulated, codon-optimized reverse transcriptional trans-activator (rtTA) mice ^[@R59]^ (obtained via the Mutant Mouse Resource and Research Center) to generate double-transgenic mice. For the α~1C~-APEX2 and β~2B~-APEX2 mice, transgene expression did not require doxycycline due to a low basal binding of rtTA protein to the *Tet* operator sequences (so-called "leak") ^[@R59]^. These expression levels result in Ca^2+^ current levels similar to native conditions in heart. The results presented were consistent across all founder lines and gender, and therefore were pooled.

Isolation of adult cardiac myocytes: {#S11}
------------------------------------

Mice ventricular myocytes were isolated by enzymatic digestion using a Langendorff perfusion apparatus as previously described ^[@R16],[@R17],[@R42],[@R43],[@R60]^. Cardiomyocytes were isolated from 8-12 week-old non-transgenic and transgenic mice.

Proximity labeling biotinylation: {#S12}
---------------------------------

Proximity labeling was performed as described ^[@R48]^ with minor modifications. Isolated ventricular cardiomyocytes were incubated in labeling solution with 0.5 μM biotin-phenol (Iris-biotech) for 30 minutes. For some experiments, during the final 10 minutes of labeling, 1 μM isoproterenol (Sigma I5627) was added. To initiate labeling, H~2~O~2~ (Sigma H1009) was added to a final concentration of 1 mM for 1 minute. Exactly 1 minute after H~2~O~2~ treatment, the labeling solution was decanted and cells were washed three times with cold quenching solution containing (in mM) 10 Sodium ascorbate (VWR 95035-692), 5 Trolox (Sigma 238813), and 10 Sodium azide (Sigma S2002). After cells were harvested by centrifugation, the quenching solution was aspirated and the pellet was flash-frozen and stored at −80 °C until streptavidin pull-down.

For biotinylation in Langendorff-perfused hearts, mice were injected with 5 mg/kg Propranolol-HCl (Sigma PHR1308) to suppress adrenergic stimulation during the isoflurane anesthesia and cardiectomy. Hearts were retrograde perfused with Krebs' solution for 10 minutes prior to addition of biotin-phenol for 15 minutes. During the final 5 minutes, 1 μM Isoproterenol (Sigma 1351005) or vehicle was added to the perfusate. Electrocardiograms were monitored throughout the experiment to ensure viability of the preparation and an isoproterenol-induced increase in heart rate.

The cells or whole heart tissue were lysed with a hand-held tip homogenizer in a solution containing (in mM), 50 Tris (tris(hydroxymethyl)aminomethane) , 150 NaCl, 10 EGTA, 10 EDTA, 1% Triton X-100 (v/v), 0.1% SDS (w/v), 10 Sodium ascorbate, 5 Trolox, and 10 Sodium azide, phosphatase inhibitors (Sigma 4906845001), protease inhibitors (Sigma 4693159001), Calpain inhibitor I (Sigma A6185) and Calpain inhibitor II (Sigma A6060). Biotin labeling of the samples was confirmed after size-fractionation of proteins on SDS-PAGE, transfer to nitrocellulose membranes, and probing with Streptavidin-HRP (Thermofisher, S911, Lot\# 1711896, 0.6mg/ml). The response to isoproterenol was assessed by immunoblotting with an anti-phospho-phospholamban (Ser16/Thr17) antibody (Cell Signaling, \#8496, Lot\#1; 1:1000 dilution).

Immunoprecipitation and Immunoblots: {#S13}
------------------------------------

Cardiomyocytes were lysed with a hand-held tip homogenizer in a 1% (v/v) Triton X-100 buffer containing (in mM): 50 Tris-HCl (pH 7.4) 150 NaCl, 10 EDTA, 10 EGTA and protease inhibitors. The lysates were incubated on ice for 30 minutes, centrifuged at 14,000 RPM at 4°C for 10 minutes and supernatants collected. Proteins were size-separated on SDS-PAGE, transferred to nitrocellulose membranes, and probed with anti-V5 antibody (Thermofisher, R960-25; 1:5000 dilution), a custom-made polyclonal anti-α~1C~ antibody (Yenzym, 1:1000 dilution) ^[@R61],[@R62]^, a custom-made polyclonal anti-β antibody (epitope: mouse residues 120-138: DSYTSRPSDSDVSLEEDRE; Yenzym, 1:1000 dilution), an anti-JPH2 antibody (Pierce, PA5-20642, lot\# NG1583142; 1:1000 dilution), an anti-calmodulin antibody (Millipore Sigma 05-173; 1:1000 dilution), a custom-made anti-RyR2 antibody (1:5000 dilution) ^[@R63]^, and an anti-K~V~1.5 antibody (Alomone, APC-150, Lot\# APC004AN0850; 1:1000 dilution). Anti-FLAG antibody (Sigma, F7425, Lot\#078M4886V) immunoprecipitations were performed, as previously described ^[@R17]^, overnight in a lysis buffer consisting of (in mM): 50 Tris-HCl pH 7.4, 150 NaCl, 0.25% Triton X-100 (v/v), 10 EDTA, 10 EGTA, 0.01 Calpain inhibitor I, 0.01 Calpain inhibitor II, and Complete protease inhibitors (1 per 7 ml, Roche). Antibody-protein complexes were collected using protein A conjugated agarose (Amersham) for 2 h, followed by 3 washes in lysis buffer. Proteins were size-separated by SDS, transferred to nitrocellulose membranes and probed with HRP-conjugated anti-FLAG antibody (Sigma, A8592), a custom-made anti-β antibody and HRP-conjugated secondary goat anti-rabbit antibody. Phospholamban phosphorylation was detected with an anti-phospho-PLB antibody. Detection of luminescence was performed with a CCD camera (Carestream Imaging). The uncut gels are shown in [Supplementary Fig. 1](#SD8){ref-type="supplementary-material"}.

Immunofluorescence: {#S14}
-------------------

Isolated cardiomyocytes were first exposed to biotin-phenol and H~2~O~2~ as described above. After quenching, the cells were fixed for 15 minutes in 4% paraformaldehyde, washed with glycine/PBS (phosphate-buffered saline) twice, treated with PBST (0.1% Triton X-100 (v/v) in PBS) for 5 minutes, and blocked with 3% BSA (w/v) in PBS for 1 hour. Indirect immunofluorescence was performed using dilutions of 1:500 of anti-V5 antibody (Thermofisher, R960-25) and 1:200 of Alexa594-labeled goat-anti-mouse antibody (Thermofisher, A11032, Lot\#2069816), and 1:800 of streptavidin-Alexa Fluor 488 conjugate (Thermofisher, S32354, Lot\# 1719656). Images were acquired using a confocal microscopy.

Processing of biotinylated proteins for mass spectrometry: {#S15}
----------------------------------------------------------

Proteins were prepared as previously described ^[@R7]^ with some modifications. A detailed protocol of the procedures used was published recently ^[@R64]^. Proteins were precipitated with Trichloroacetic acid (TCA; Sigma T9159) and then centrifuged at 21,130 × g at 4 °C for 10 minutes. The pellet was washed with −20 °C cold acetone (Sigma 650501), vortexed, and centrifuged at 21,130 × g at 4 °C for 10 minutes. Following centrifugation, acetone was aspirated and the pellet was acetone-washed again three more times. After the last washing step, the pellet was resuspended in: 8M urea, 100 mM sodium phosphate pH 8, 100 mM NH~4~HCO~3~, and 1% SDS (w/v) and rotated at room temperature until fully dissolved. Re-suspended proteins were centrifuged at 21,130 × g at room temperature for 10 minutes and the cleared supernatant was transferred to a new microcentrifuge tube. To reduce disulfides, 10 mM TCEP-HCl (Thermo Fisher Scientific PG82089) in Milli-Q water titrated to pH 7.5 with NaOH was added. To alkylate free Cys, freshly prepared 400 mM iodoacetamide (Thermo Fisher Scientific 90034) stock solution in 50 mM ammonium bicarbonate was added to the supernatant to a final concentration of 20 mM, immediately vortexed, and incubated in the dark for 25 minutes at room temperature. After alkylation, freshly prepared DTT (dithiothreitol) stock solution was added to 50 mM final concentration to quench alkylation. Water was added to each sample to reach a final concentration of 4 M urea and 0.5% (w/v) of SDS.

A 100 μL suspension equivalent per sample of streptavidin magnetic beads (Thermo Fisher Scientific \#88817) was washed twice with 4 M urea, 0.5% SDS (w/v), 100 mM sodium phosphate pH 8 and was added to each sample (about 1 mg), diluting each sample with an equal amount of water to reach a final concentration of 2 M urea, 0.25% SDS (w/v), 50 mM sodium phosphate pH 8 during pulldown. The tubes were rotated overnight at 4 °C. Following streptavidin pull-down, the magnetic beads were washed three times with 4 M urea, 0.5% SDS (w/v), 100 mM sodium phosphate pH 8, and three times with the same buffer without SDS. The beads were transferred to new tubes for the last wash step. Before final pulldown of the beads for mass spectrometry analysis, 5% of beads resuspension was removed for streptavidin-HRP blotting.

On-bead digestion and TMT labeling: {#S16}
-----------------------------------

The samples were prepared as previously described ^[@R7]^. Liquid reagents used were HPLC quality grade. Washed beads were re-suspended in 50 μL of 200mM EPPS (4-(2-Hydroxyethyl)-1-piperazinepropanesulfonic acid) buffer pH 8.5, 2% acetonitrile (v/v) with 1 μL of LysC stock solution (2 mg/ml, Wako), vortexed briefly and incubated at 37°C for 3 hr. Then, 50 μL of trypsin stock (Promega \#V5111) diluted 1:100 (v/v) in 200 mM EPPS pH 8.5 was added. After mixing, digests were incubated at 37°C overnight and beads were magnetically removed. Peptides were directly labeled after digest. For this, acetonitrile was added to a concentration of 30% (v/v) and peptides were labeled with TMT 10-plex or 11-plex reagents (Thermo Fisher Scientific \#90406 and \#A34807) for 1 hr. Reactions were quenched with hydroxylamine at a final concentration of 0.3% (v/v) for 15 minutes and 1% of labeled peptides were analyzed for efficiency of label incorporation and relative ratios by mass spectrometry. After quenching, peptide solutions were acidified with formic acid, trifluoroacetic acid (TFA) was added to a concentration of 0.1% and peptides were desalted and fractionated by high pH reversed phase chromatography (Thermo Fisher Scientific \#84868). After loading of labeled peptides onto pre-conditioned columns and a single wash with water, excess unincorporated TMT label was removed by washing reversed phase columns once with 0.1% trimethylamine (TEA) buffer containing 5% acetonitrile. Samples were fractionated under alkaline conditions into 12 fractions with increasing concentrations of acetonitrile: 10%, 12.5%, 15%, 17.5%, 20%, 25%, 30%, 35%, 40%, 50%, 65% and 80%. Fractions 1 and 7, 2 and 8, 3 and 9, 4 and 10, 5 and 11, 6 and 12 were pooled to obtain 6 final pooled fractions for subsequent analysis. Pooled fractions were dried to completion and further purified and desalted by acidic C~18~ solid phase extraction (StageTip). Labeled peptides were finally re-suspended in 1% formic acid (v/v) and 3% acetonitrile (v/v).

Whole cell proteomics: Cell lysis, protein digest and TMT labeling mass spectrometry analysis: {#S17}
----------------------------------------------------------------------------------------------

Cells were lysed by homogenization (QIAshredder cartriges, Qiagen) in lysis buffer (2% SDS, 150 mM NaCl, 50 mM Tris pH 7.4). Lysates were reduced with 5 mM DTT, alkylated with 15 mM iodoacetamide for 30 minutes in the dark, alkylation reactions quenched with freshly prepared DTT added to a concentration of 50 mM and proteins precipitated by methanol/chloroform precipitation. Digests were carried out in 1M urea freshly prepared in 200 mM EPPS pH 8.5 in presence of 2% acetonitrile (v/v) with LysC (Wako, 2 mg/ml, used 1:75 w/w protease:substrates during digest) for 3 hours at room temperature and after subsequent addition of trypsin (Promega \#V5111, stock 1:100 w/w protease:substrates) over night at 37°C. Missed cleavage rate was assayed from a small aliquot by mass spectrometry. For whole proteome analysis, digests containing approximately 60 μg of peptide material were directly labeled with TMT reagents (Thermo Fisher Scientific). Labeling efficiency and TMT ratios were assayed by mass spectrometry, while labeling reactions were stored at −80°C. After quenching of TMT labeling reactions with hydroxylamine, TMT labeling reactions were mixed, solvent evaporated to near completion and TMT labeled peptides purified and desalted by acidic reversed phase C~18~ chromatography. Peptides were then fractionated by alkaline reversed phase chromatography into 96 fractions and combined into 24 samples.

Mass spectrometry analysis: {#S18}
---------------------------

Data collection followed a MultiNotch MS^3^ TMT method ^[@R65]^ using an Orbitrap Lumos mass spectrometer coupled to a Proxeon EASY-nLC 1200 liquid chromatography (LC) system (both Thermo Fisher Scientific). The capillary column used was packed with C~18~ resin (35 cm length, 75 μm inner diameter, matrix 2.6 μm Accucore (Thermo Fisher Scientific)). Peptides of each fraction were separated for 4 hours over acidic acetonitrile gradients by LC prior to mass spectrometry (MS) analysis. The scan sequence started with an MS^1^ scan (Orbitrap analysis; resolution 120,000; mass range 400--1400 Th). MS^2^ analysis followed collision-induced dissociation (CID, CE=35) with a maximum ion injection time of 150-300 ms and an isolation window of 0.4 m/z. In order to obtain quantitative information, MS^3^ precursors were fragmented by high-energy collision-induced dissociation (HCD) and analyzed in the Orbitrap at a resolution of 50,000 at 200 Th. Further details on LC and MS parameters and settings used were described recently ^[@R66]^.

Peptides were searched with a SEQUEST (v.28, rev. 12) based software against a size-sorted forward and reverse database of the *M. musculus* proteome (Uniprot 07/2014) with added common contaminant proteins. For this, spectra were first converted to mzXML. Searches were performed using a mass tolerance of 20 ppm for precursors and a fragment ion tolerance of 0.9 Da. For the searches maximally 2 missed cleavages per peptide were allowed. We searched dynamically for oxidized methionine residues (+15.9949 Da) and where indicated for phospho-modification of S,T and Y residues (+79.9663 Da). We applied a target decoy database strategy and a false discovery rate (FDR) of 1% was set for peptide-spectrum matches following filtering by linear discriminant analysis (LDA) ^[@R26],[@R66]^. The FDR for final collapsed proteins was 1%. MS^1^ data were calibrated post search and searches performed again. A modified version of the Ascore algorithm was used to quantify the confidence assignment of phosphorylation sites. Phosphorylation localized to particular residues required Ascore values \> 13 (p ≤ 0.05) for confident localization ^[@R26]^. Quantitative information on peptides was derived from MS^3^ scans. Quant tables were generated requiring an MS^2^ isolation specificity of \>70% for each peptide and a sum of TMT signal to noise (s/n) of \>200 over all channels for any given peptide and exported to Excel and further processed therein. Details of the TMT intensity quantification method and further search parameters applied were described previously previously ^[@R67]^. Proteomics raw data and search results were deposited in the PRIDE archive ^[@R68],[@R69]^ and can be accessed under ProteomeXchange accession nunbers: PXD014499, PXD014500, PXD014501.

The relative summed TMT s/n for proteins between two experimental conditions (referred to as "enrichment" in the text) was calculated from the sum of TMT s/n for all peptides quantified of a given protein. For gene ontology (GO) term enrichment, the BINGO package in Cytoscape was used ^[@R70]^. Scaled quantification data were subjected to two-way clustering (JMP software package) and changes in enrichment were analyzed using Graphpad Prism 8 (Graphpad Software). Statistical significance was determined by multiple t-tests without correction for multiple comparisons and α=0.05. Data for relative protein quantification accompany this paper in the form of [Supplementary Data Tables 1](#SD2){ref-type="supplementary-material"},[3](#SD4){ref-type="supplementary-material"}-[6](#SD7){ref-type="supplementary-material"}, and can be accessed online.

Purification of GFP-conjugated Rad and phosphoproteomic analysis: {#S19}
-----------------------------------------------------------------

HEK293T cells were cultured in DMEM with 10% FBS and 1% Pen-Strep. Cells were transfected with GFP-Rad using lipofectamine 2000 as described above. Media was changed 4-6 hours after transfection. After 24 hours, cells were treated with trypsin and spun down for 5 minutes at 1000 rpm. Cells were then resuspended in PBS with 10 μM forskolin for 5 minutes. After washing cell pellets three times with phosphate-buffered saline (PBS), cells were frozen at −80°C. Cold cell pellets were lysed in PBS with 0.1% triton X-100 (v/v, Sigma) and a phosphatase inhibitor mixture (PhosSTOP, Roche) by pipetting up and down several times. Lysates were homogenized by passing them through QIAshredder cartridges (Qiagen) and incubated with GFP-trap agarose beads (Chromotek, Germany) for 4 hours at 4°C with constant rotation. Beads were washed 3 times with PBS with 0.1% (v/v) Triton and three times with detergent-free PBS and subjected to on-bead digest with trypsin (Promega \#V5111), LysC (Wako) or ArgC (Promega \#V1881, ArgC digestion buffer 50 mM Tris-HCL pH 7.8, 5 mM CaCl~2~, 2 mM EDTA, 2% acetonitrile (v/v)) separately as described above overnight at 37°C. After acidification, peptides were purified by reversed phase C~18~ chromatography and subjected to MS/MS analysis. For this, the same parameters as above for MS^1^ and MS^2^ scans were used with an isolation window of 1.2 Da and taking neutral loss of 97.9763 Da into account with multi-stage activation (MSA) set for MS^2^ scans. Analysis of phospho-site localization was performed as described above.

Fractional shortening: {#S20}
----------------------

Freshly isolated myocytes were perfused with a Tyrode's solution containing 1.8 mM CaCl~2~. Myocytes were field stimulated at 1-Hz. Nisoldipine (300 nM) dissolved in Tyrode's solution was then superfused. Fractional shortening of sarcomere length was measured using the SarcLen module of Ionoptix.

Whole cell patch clamp electrophysiology: {#S21}
-----------------------------------------

Isolated cardiomyocytes or HEK cells on glass 8×8 mm coverslips were placed in Bioptechs Delta T Dishes filled with solution containing (in mM): 112 NaCl, 5.4 KCl, 1.7 NaH~2~PO4. 1.6 MgCl~2~, 20.4 HEPES (pH 7.2), 30 Taurine, 2 DL-Carnitine, 10.3 Creatine, 5.4 Glucose. The petri dishes were mounted on the stage of an inverted microscope and served as a perfusion chamber. After establishing a seal and achieving whole-cell configuration, external solutions were changed by fast local perfusion method.

For cardiomyocytes, pipette resistance was between 1-3 MΩ. Membrane currents were measured by conventional (ruptured) whole-cell patch-clamp method using a MultiClamp 700B or Axopath200B amplifier and pCLAMP 10.7 software (Molecular Devices). Capacitance transients and series resistance were compensated. Voltage was corrected for liquid junction potential (−10 mV) during analysis. Leak currents were subtracted by a P/4 protocol. The parameters of voltage-dependent activation were obtained using a modified Boltzmann distribution: I(V)= G~max~ \* (V-E~rev~)/\[1 + exp(V-V~50~)/V~c~)\], where I(V) is peak current, G~max~ is maximal conductance, E~rev~ is reversal potential, V~50~ is the midpoint, and V~c~ is the slope factor.

The pipette solution contained (in mM): 40 CsCI, 80 Cesium Gluconate, 10 BAPTA (1,2-bis(*o*-aminophenoxy)ethane- *N*,*N*,*N′*, N′-tetraacetic acid), 1 MgCl~2~, 4 Mg-ATP, 2 CaCl~2~, and 10 HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), adjusted to pH 7.2 with CsOH. After the isolated cardiomyocytes were dialyzed and adequately buffered with 10 mM BAPTA in the internal solution, cells were superfused with (in mM): 140 TEA-Cl (Tetraethylammonium chloride), 1.8 CaCl~2~, 1 MgCl~2~, 10 glucose, and 10 HEPES, adjusted to pH 7.4 with CsOH. To measure peak currents, the cell membrane potential was held at −50 mV and stepped to +0 mV for 350 ms every 10 s. To evaluate the current-voltage (I-V) relationship in cardiomyocytes, the same protocol was repeated with steps between −40 mV to +60 mV in 10 mV increments. Nisoldipine (Santa Cruz) was stored protected from light at −20 °C as 3 mM stock in ethanol. The final dilution of nisoldipine to 300 nM was in the extracellular recording solution immediately prior to the experiment. Isoproterenol (Sigma I5627) and Forskolin (Santa Cruz) were prepared daily and diluted in extracellular solution.

For HEK293T cell experiments involving the Forskolin-induced stimulation of Ca~V~1.2, Ca~V~1.3 and Ca~V~2.2 currents, perforated whole-cell patch clamp technique was implemented to minimize current run-down and preserve the intracellular milieu. Amphotericin B (Sigma A9528) was initially dissolved in DMSO (20 mg/ml) and used in the pipette solution at a final concentration of 200 μg/ml. The tip of pipette was filled with amphotericin-free solution (in mM): 80 Cesium Gluconate, 40 CsCI, 10 HEPES, 10 BAPTA, 1 MgCI~2~, 1 Mg-ATP, pH adjusted to 7.2 with CsOH. The pipette was backfilled with (in mM): 125 CsCI, 10 HEPES, 4 CaCI~2~, 1 MgCI~2,~ pH-7.2 with CsOH; containing amphotericin, 200 μg/ml. CaCI~2~ (4 mM) was added to the patch electrode solution to enable the detection of conversion from perforated to ruptured configuration. The external solution contained (in mM): 130 tetraethylammonium methanesulfonate, 10 HEPES, 1 MgCI~2~,10 (with Rad expression) or 2 (without Rad expression) BaCI~2~, 5 Glucose. For experiments with HEK293T cells, in addition to step protocols, we used a ramp protocol with a 200-ms voltage ramp from −60 to +60 mV (0.6 V/s) applied every 10-seconds to monitor the I-V relationship. All experiments were performed at room temperature, 22 ± 1° C. Cells were selected based on co-transfection of a vector containing GFP in the absence of Rad, and GFP-conjugated Rad for the experiments with Rad transfected. For both cardiomyocytes and HEK293T cells, cells without a stable baseline (potentially due to run-down or run-up) were not studied.

Voltage steps protocol used in cardiomyocytes studies evaluated I~Ipeak~ = I~peak~ (V), which was recalculated in CLAMPFIT to G=G(V) as G=I/(V-E~rev~). For HEK cells experiments, we used a ramp protocol ([Extended Data Fig. 8b](#F12){ref-type="fig"}). The experimental records were I=I(t), where t=time. We transformed these records to I=I(V), which was then further transformed to G=G(V) in CLAMPFIT (see [Extended Data Fig. 8b](#F12){ref-type="fig"}). The parameters of voltage-dependent activation were obtained using a modified Boltzmann distribution. A nonlinear fit with Boltzmann sigmoidal function was done in Prism (GraphPad) with goodness of fit: R^2^\>0.99.

Single channel patch clamp electrophysiology: {#S22}
---------------------------------------------

Cell-attached single-channel recordings were performed at room temperature as previously described ^[@R71],[@R72]^. Patch pipettes (5--10 MΩ) were pulled from ultra-thick-walled borosilicate glass (BF200-116-10, Sutter Instruments), and coated with Sylgard. Currents were filtered at 2 kHz. The pipette solution contained (in mM): 140 tetraethylammonium methanesulfonate; 10 HEPES; 40 BaCl~2~; at 300 mOsm/L, adjusted with tetraethylammonium methanesulfonate; and pH 7.4 adjusted with tetraethylammonium hydroxide. To maintain the membrane potential at 0 mV, the bath contained (in mM): 132 potassium glutamate; 5 KCl; 5 NaCl; 3 MgCl~2~; 2 EGTA (ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid); 10 glucose; 20 HEPES; at 300 mOsm/L adjusted with glucose; and pH 7.4 adjusted with NaOH. Cell-attached single-channel currents were measured during 200 ms voltage ramps between −80 to +70 mV (portions between −50 and 40 mV displayed and analyzed). For each patch, we recorded 80-120 sweeps with a repetition interval of 10 seconds.

The sample size for the P~o~-V relationships:

  ------------- -------------------------- ------------
  α~1C~         n = 10 (3 transfections)   933 sweeps
  α~1C~ +PKA    n = 5 (2 transfections)    450 sweeps
  Rad           n = 5 (3 transfections)    372 sweeps
  Rad+PKA       n = 8 (3 transfections)    527 sweeps
  Rad Mut       n = 6 (4 transfections)    388 sweeps
  Rad Mut+PKA   n = 5 (3 transfections)    439 sweeps
  ------------- -------------------------- ------------

The modal analysis are histograms of single-trial average P~o~ values obtained from one-channel patches. For P~o~-V analysis, we conservatively corrected for shifts in voltage. The number of sweeps is as follows:

  -------------- -----------------------------------------
  α~1C~ alone:   281 sweeps (from 3 one-channel patches)
  Rad:           372 sweeps (from 5 one-channel patches)
  Rad + PKA:     311 sweeps (from 3 one-channel patches)
  -------------- -----------------------------------------

Flow Cytometric FRET 2-hybrid assay: {#S23}
------------------------------------

For flow cytometric FRET assay, HEK293 cells (ATCC CRL1573) were cultured in 12 well plates and transfected with polyethylenimine (PEI) 25 kDa linear polymer (Polysciences \#2396602). Briefly, 1.5 μg of Cerulean (Cer) and Venus (Ven) -tagged cDNA pairs were mixed together in 100 μl of serum-free DMEM media and 6 μl of PEI is added to each sterile tube. FRET experiments were performed 1-day post-transfection. Protein synthesis inhibitor cycloheximide (100 μM) was added to cells 2-hrs prior to experimentation to halt synthesis of new fluorophores to allow existing fluorophores to fully mature.

For FRET measurements, we utilized an LSR II (BD Biosciences) flow cytometer equipped with 405 nm, 488 nm, and 633 nm lasers for excitation and 18 different emission channels. Forward and side scatter signals were detected and used to gate for single, and healthy cells. For determining FRET efficiency, we measured three distinct fluorescence signals: (1) *S*~Cer~ corresponding to cerulean emission is measured through the BV421 channel (excitation, 405 nm; emission, 450/50), (2) *S*~Ven~ corresponding to venus emission measured via FITC channel (excitation, 405 nm; dichroic, 505LP; emission, 525/50), and (3) *S*~FRET~ corresponding to FRET emission via the BV510 channel (excitation, 405 nm; dichroic, 505LP; emission, 525/50). These raw fluorescence measurements are subsequently used to obtain Ven~direct~ (venus emission due to direct excitation), Cer~direct~ (cerulean emission due to direct excitation), and Ven~FRET~ (venus emission due to FRET excitation). Flow cytometric signals were collected at medium flow rate (2k-8k events/sec). Fluorescence data was exported as FCS 3.0 files for further processing and analysis using custom MATLAB functions (MathWorks).

For each experimental run on the flow cytometer, we performed several control experiments: (1) Background fluorescence level for each fluorescent channel (*BG*~Cer~, *BG*~Ven~, and *BG*~FRET~) was obtained by measuring fluorescence from cells exposed to PEI without any fluorophore containing plasmids. (2) Cells expressing Ven fluorophore alone were utilized to measure spectral crosstalk parameter *R*~A1~, corresponding to bleed-through of Ven fluorescence into the FRET channel. (3) Cells expressing cerulean fluorophore alone were used to measure spectral crosstalk parameter *R*~D1~ and *R*~D2~, corresponding to bleed-through of cerulean fluorescence into FRET and Ven channels respectively. (4) FRET measurements also require determination of instrument-specific calibration parameters g~Ven~ / g~Cer~ and *f*~Ven~ / *f*~Cer~, corresponding to ratios of fluorescence excitation and emission for Ven to cerulean fluorophores. These parameters also incorporate fluorophore-dependent aspects including molar extinction (for *g*) and quantum yield (for *f*) as well as instrument specific parameters including laser power, attenuation by optical components, as well as photodetection, amplification, and digitization of fluorescence. For determination of these parameters, we utilized Cer-Ven dimers with four different linker lengths (5, 32, 40, and 228). (5) Co-expression of cerulean and Ven fluorophores provided estimates for concentration-dependent collisional FRET.

For our experiments, *R*~A1~ \~ 0.11, *R*~D1~ \~ 2.8, and *R*~D2~ \~ 0.006. We observed only minor day-to-day variation in these measurements. For each cell, spectral cross-talk was subtracted as follows: $$Cer_{\text{direct}} = R_{D1} \cdot S_{\text{Cer}},\, Ven_{\text{direct}} = R_{A1} \cdot (S_{\text{Ven}} - R_{D2} \cdot S_{\text{Cer}},\;\text{and}\; Ven_{\text{FRET}} = S_{\text{FRET}} - R_{A1} \cdot (S_{\text{Ven}} - R_{D2} \cdot S_{\text{Cer}})\, - R_{D1} \cdot S_{\text{Cer}}.$$

Following spectral unmixing, we obtained *g*~Ven~ / *g*~Cer~ and *f*~Ven~ / *f*~Cer~ from data for Cer-Ven dimers by determining the slope and intercept for the following linear relationship: $$\frac{Ven_{FRET}}{Cer_{\text{direct}}} = \frac{g_{\text{Cer}}}{g_{Ven}}\bullet\frac{Ven_{direct}}{Cer_{\text{direct}}} - \frac{f_{Ven}}{f_{Cer}}$$

For typical experiments, *g*~Ven~ / *g*~Cer~ = 0.0194 and *f*~Ven~ / *f*~Cer~ = 2.3441. Having obtained these calibration values, donor-centric FRET efficiencies were computed as, $$E_{D} = \frac{Ven_{\text{FRET}}}{Ven_{\text{FRET}} + \frac{f_{Ven}}{f_{Cer}}\bullet Cer_{\text{direct}}}$$

For Cer-Ven dimers, FRET efficiencies of \~ 0.55, 0.38, and 0.05 were obtained for linker lengths 5, 32, and 228 respectively, matching previous work ^[@R30]^. The relative proportion of Cerulean and Venus fluorophores in each cell was determined as *N*~Cer~ = Cer~direct~ / (1 - *E*~D~) and *N*~Ven~ = Ven~direct~ / (*g*~Ven~ / *g*~Cer~ × *f*~Ven~ / *f*~Cer~ ). To construct FRET 2-hybrid binding curves, we imposed a 1:1 binding isotherm as in previous studies ^[@R30]^. For each FRET pairs, *K*~d,EFF~ and *E*~D,max~ and 95% - confidence intervals were obtained by constrained least squares fit.

For [Fig. 4b](#F4){ref-type="fig"}-[c](#F4){ref-type="fig"} and [Extended Data Fig. 9a](#F13){ref-type="fig"}-[b](#F13){ref-type="fig"}, we show all the individual cells from two different transfections. We fit these data with the equation: E~D~ = E~max~\*\[Ven-Rad\]~free~/(\[Ven-Rad\]~free~ + kdeff) using least squares algorithm (<https://www.mathworks.com/help/stats/nlinfit.html>). The Kdeff fit value based on all the data points is shown as the bar in [Extended Data Fig. 9c](#F13){ref-type="fig"}. The error is calculated by the fitting algorithm as a 95%-confidence interval on the fit parameter: <https://www.mathworks.com/help/stats/nlparci.html>).

Statistical Analysis: {#S24}
---------------------

Results are presented as mean ± SEM. For comparisons between two groups, Student's t-test was used. Statistical analyses were performed using Prism 8 (Graphpad Software). For multiple group comparisons, a one-way ANOVA followed by either Dunnett's or Tukey's post-hoc test were performed using Prism 8. Differences were considered statistically significant at values of *P* \< 0.05.

Extended Data {#S25}
=============

![Putative PKA phosphorylation sites in α~1C~ and β~2B~ subunit.\
**(a)** The 35 putative PKA phosphorylation sites in rabbit α~1C~. The 51 residues in red are either predicted phosphorylation sites or within the immediate region of the predicted phosphorylation sites. All 51 residues were replaced with Ala in the 35-mutant α~1C~ transgenic mice. **(b)** Combined bar and column scatter plot of Boltzmann function parameters V~50~. Mean ± SEM. \*\* *P* \<0.01; \*\*\* *P* \<0.001; \*\*\*\* *P* \<0.0001 by paired two-tailed t-test. pWT α, n= 19; 35-α mutant, n= 14; 28-β mutant, n= 16; 35-α mutant X 28-β mutant, n= 24. Specific *P* values can be found in the Source Data associated with this figure. **(c)** Graph of isoproterenol and forskolin-induced increase in nisoldipine-resistant current stratified by total basal current density before nisoldipine. **(d)** The 28 putative PKA phosphorylation sites in the N-terminal (NT), Hook, GK and C-terminal (CT) domains of β~2B~. The 37 residues in red are either predicted phosphorylation sites or within the immediate vicinity of predicted phosphorylation sites, and were mutated to Ala in the 28-mutant GFP-tagged β~2B~ transgenic mice. **(e)** Fluorescence imaging of isolated cardiomyocytes expressing GFP-tagged 28-β mutant. Representative of images from more than 5 biologically independent mice. **(f)** Anti-β antibody immunoblot of cleared lysates from doxycycline-fed 35-mutant α~1C~ transgenic mice or 35-mutant α~1C~ X GFP-tagged 28-mutant β~2B~ expressing mice hearts. Representative of immunoblots obtained from at least 3 biologically independent mice. **(g)** Anti-FLAG antibody (upper) and anti-β antibody (lower) immunoblots of anti-FLAG antibody immunoprecipitations from cleared lysates of hearts from pWT, 35-α and three 35-α X GFP-tagged-28-β expressing mice. Representative images of two independent experiments. For source gel data, see [Supplementary Fig. 1](#SD8){ref-type="supplementary-material"}.](nihms-1546056-f0005){#F5}

![Trafficking and function of APEX2-conjugated Ca~V~1.2 channels subunits in heart.\
**(a)** Exemplar current-voltage relationship of Ca^2+^ currents from α~1C~-APEX2 mice cardiomyocytes acquired in absence (black trace) and presence of nisoldipine (red trace). Inset scale bars: horizontal 100 ms, vertical 10 pA/pF. Representative of 5 experiments. **(b)** Time course of changes in sarcomere length after superfusion of nisoldipine-containing solution. Representative of 7 experiments **(c)** Percent-shortening in the presence of nisoldipine. Mean ± SEM. \*\*\*\*, *P* \<0.0001 by unpaired two-tailed t-test. n=12, 7 cardiomyocytes, respectively. **(d)** Immunofluorescence of cardiomyocytes isolated from α~1C~-APEX2 and β~2B~-APEX2 expressing mice exposed to biotin-phenol and H~2~O~2~ or no H~2~O~2~. Nuclear labeling with DAPI stain. Scale bar = 5 μm. Representative of 5 and 8 cardiomyocytes from 2 and 3 mice respectively. **(e)** Streptavidin-horseradish peroxidase (HRP) blot of lysates of isolated ventricular cardiomyocytes. Blot representative of 5 similar experiments. **(f)** Exemplar whole-cell Ca~V~1.2 currents recorded from cardiomyocytes of α~1C~-APEX2 transgenic mice. Black trace: 300 nM nisoldipine; blue trace: 200 nM isoproterenol + nisoldipine. Representative of 9 cells from 2 biologically independent mice. **(g)** Same as (f) except from β~2B~-APEX2 transgenic mice. Black trace: control; blue trace: 200 nM isoproterenol. Representative of 7 experiments from 2 biologically independent mice. **(h-j)** Anti-phospho-phospholamban antibody immunoblot of isolated cardiomyocytes exposed to 1 μM isoproterenol. For cardiomyocytes isolated from α~1C~-APEX2 and β~2B~-APEX2 mice, the cardiomyocytes were exposed to isoproterenol after incubation with biotin-phenol. Blots representative of 3 independent experiments from at least 5 biologically independent mice for each genotype. **(k)** Same as (h-j) except whole heart exposed to 1 μM isoproterenol for 5 minutes after infusion of biotin-phenol. Blots representative of at least 5 biologically independent mice for no isoproterenol and at least 5 biologically independent mice for isoproterenol. For source gel data, see [Supplementary Fig. 1](#SD8){ref-type="supplementary-material"}.](nihms-1546056-f0006){#F6}

![Analysis of proteins quantified by mass spectrometry in cardiomyocytes isolated from α~1C~-APEX2 and β~2B~-APEX2 mice.\
**(a)** Proteins with a ratio of \>2 (measured by normalized TMT signal/noise) in the experimental conditions compared to a no-labeling control (no H~2~O~2~) are sorted by spectral counts. The 150 proteins with the highest peptide counts are displayed in the color-coded table. α~1C~-APEX2 and β~2B~-APEX2 data were collected in biological duplicate experiments. The full table with 3883 proteins quantified by multiplexed SPS MS^3^ TMT mass spectrometry is reported in [Supplementary Data Table 1](#SD2){ref-type="supplementary-material"}. **(b)** Prefuse force directed map of proteins from (a). Peptide counts were used as weight. Proteins mapping to the GO-terms "Z disc" are colored in green, to "membrane" in yellow and to both in purple. The α~1C~-APEX2 and β~2B~-APEX2 are colored in blue. **(c)** Gene-ontology (GO) term (cellular localization) enrichment for proteins in (a). The full table is reported in [Supplementary Data Table 2](#SD3){ref-type="supplementary-material"}.](nihms-1546056-f0007){#F7}

![Two-way hierarchical clustering of scaled data from [Fig. 2](#F2){ref-type="fig"}.\
**(a)** Dendrogram showing two-way hierarchical clustering of scaled TMT signal to noise (s/n) data for streptavidin-purified proteins from α~1C~-APEX2 expressing cardiomyocytes after vehicle or after isoproterenol stimulation. Scaled relative TMT protein quantification data for 1951 proteins from biological quintuplicate α~1C~-APEX2. Clustering used Ward's minimum variance method. **(b)** Dendrogram showing two-way hierarchical clustering of scaled relative quantification data for 1936 proteins from biological triplicate β~2B~-APEX2 experiments. Heterogeneity between cardiomyocyte preparations from different mice is apparent. **(c)** Dendrogram showing two-way hierarchical clustering of scaled relative quantification data for 2610 proteins from whole-organ α~1C~-APEX without or with perfusion of isoproterenol. Prominent heterogeneity in relative protein quantification between hearts is apparent. Position of Rad is indicated by a red line. In this experiment, the individual hearts are not paired. **(d)** Dendrogram showing two-way hierarchical clustering of scaled TMT signal to noise (s/n) data from non-transgenic (NTG) cardiomyocytes under isoproterenol stimulation or with vehicle. Scaled data of 4622 quantified proteins from biological quadruplicate experiment are displayed. Pairing of samples is apparent.](nihms-1546056-f0008){#F8}

![Isoproterenol-induced change in Rad detected by mass spectrometry.\
**(a)** MS^2^ spectrum and TMT quantification parameters of a Rad peptide changed upon isoproterenol treatment of murine hearts. The MS^2^ spectrum used for identification of the peptide: IFGGIEDGPEAEAAGHTYDR mapping to Rad is displayed. y and b ion m/z identified in the spectrum and their deviation from theoretical m/z are displayed on the left. Precursor mass was measured as 778.71 Da with a charge of +3. Peptide modifications were +229.16 Da for TMT on the peptide N-terminus and lysine residues, +57.02 Da for cysteine alkylation and +15.99 for methionine oxidation. Ion injection times, isolation specificity, sum of signal to noise (SN) over all TMT channels, TMT raw intensities, adjusted intensities and final SN intensities used for relative quantification as well as SPS ion m/z are displayed. **(b)** Table showing gene names of proteins with *P* \< 0.05 for the three approaches: cardiomyocytes isolated from α~1C~-APEX and β~2B~-APEX mice, and α~1C~-APEX hearts. Yellow-highlighted genes are in common amongst groups, but note for Mast2, the fold-change is not consistent. D3Z0N2\* is a single peptide with the sequence ESFDSQSLINNQSK and its abundance is reduced by isoproterenol-treatment in non-transgenic cardiomyocytes to 27% likely by post-translational modification (P =0.000002, see [Fig. 3](#F3){ref-type="fig"} and [Supplementary Data Table 6](#SD7){ref-type="supplementary-material"}). Data are mean fold-change for 5 pairs of biologically independent pairs of α~1C~-APEX2 cardiomyocyte samples, 3 pairs of biologically independent pairs of β~2B~-APEX cardiomyocyte samples, and 10 α~1C~-APEX2 hearts, 5 without isoproterenol and 5 with isoproterenol. Non-adjusted unpaired two-tailed t-test. **(c)** Venn diagram of the data from (b). Proteins: Rad = Rrad; PKA catalytic subunit= Prkaca; Acss1 = acyl-CoA synthetase short chain family member 1. Rad is the only protein consistently changed amongst the three approaches.](nihms-1546056-f0009){#F9}

![Rad is required for Forskolin-induced activation of heterologously expressed Ca~V~1.2 channels.\
**(a)** Exemplar whole-cell Ca~V~1.2 currents elicited from step depolarizations recorded from HEK293T cells expressing Rad. Pulses every 10-s before (black traces) and during Forskolin (blue traces). Representative of at least 10 cells. **(b)** Methodology used for generating G/V curves. i. Upper: 200-ms voltage ramp from −60 mV to + 60 mV was applied every 10-s. Lower: Current traces -- average of 3 traces before Forskolin (black) and 3 traces after Forskolin (blue). ii. Conversion of time scale to applied voltage. iii. Convert to G-V relationship. (G). Fold-change was calculated at G~max~. **(c)** Graph of Forskolin-induced fold-change in current stratified by basal current density. **(d)** Exemplar traces of Ba^2+^ currents in absence and presence of Rad elicited by voltage ramp every 10-s. Black traces before and blue traces after Forskolin. no Rad:7 cells; Rad:16 cells. **(e)** Boltzmann function parameter V~50~. Mean ± SEM. \*\* *P* \<0.01 by paired two-tailed t-test. n= 7, 16, left to right. **(f-g)** Graphs of ratio of current after Forskolin to current before Forskolin for cells transfected without and with Rad. Representative of analyses for 3 cells for each condition. **(h-l)** The distribution of sweep-by-sweep average *P*~O~ (single trial *P*~O~). (h) In absence of Rad, sweeps with no openings or blank sweeps are rare (10%), while most sweeps exhibit either intermediate-high levels of openings. (k) Pale blue lines are conditional P~o~-voltage relationship obtained for sweeps exhibiting high activity. Blue line is Boltzmann fit. (i) Fraction of blank sweeps is increased with expression of Rad. (j) If PKA catalytic domain is also co-expressed with Rad, the fraction of blank sweeps is reduced and there is a resurgence of the high activity mode. (l) Same as (k) but with Rad and PKA expression.](nihms-1546056-f0010){#F10}

![PKA phosphorylation sites in mouse Rad.\
**(a)** Serine/threonine residues (purple-highlighted) mutated to alanine in the 14-SA mutant. **(b)** Mass spectrometry identification of phosphorylated residues on Rad enriched with an anti-GFP nanobody matrix from HEK cells expressing GFP-Rad and treated with forskolin. The number of spectral counts is plotted against the position of the phosphorylated amino acids in Rad. 534 aggregated phosphopeptides were detected from two independent experiments. **(c)** The database entry of phosphorylation sites identified previously in Rad is displayed. The highest level of Rad phosphorylation was detected in the heart. Peptides with phosphorylated Ser residues (bold, red) on positions 25, 38 and 300 (mapped to Rad expression constructs used in this study) were detected. (<https://phosphomouse.hms.harvard.edu/site_view.php?ref=IPI00133102>). **(d)** Serine residues mutated to alanine in 4-SA mutant indicated by arrows.](nihms-1546056-f0011){#F11}

![Binding of Rad and β~2B~ is required for regulation of Forskolin-induced stimulation of voltage-gated Ca^2+^ channels.\
**(a)** Alanine substitutions of Rad at residues R208 and L235 (yellow-highlighted), and **(b)** alanine substitutions at residues D244, D320 and D322 (yellow-highlighted) of β~2B~ were created to attenuate Rad binding to β as described previously ^[@R28],[@R29]^. **(c)** Ba^2+^ current of Ca~V~1.2 channels elicited by voltage ramp every 10 s from −60 mV to +60 mV over 200 ms. Black traces before and blue traces after Forskolin. Representative of 20 and 15 cells, from top to bottom. **(d)** Boltzmann function parameter V~50~. Mean ± SEM. \*\* *P* \<0.001 by paired two-tailed t-test. Data for WT Rad is same as [Fig. 3h](#F3){ref-type="fig"}. Specific *P* values can be found in the Source Data associated with this figure. N= 16, 19, 13, from left to right. **(e)** Fold-change (Forskolin vs. No Forskolin) in G~max~. Mean ± SEM. *P* \< 0.0001 by one-way ANOVA; \*\*\*\* *P* \<0.0001 by Dunnett's test. Data for WT Rad and WT β~2B~ is same as [Fig. 4e](#F4){ref-type="fig"}. n= 7, 7, 9 cells, from left to right. **(f)** Fold-change (forskolin vs. no forskolin) in G~max~. Mean ± SEM. *P* \< 0.001 by one-way ANOVA; \*\*\* *P* \< 0.001 by Dunnett's test. Data for WT Rad and WT β~2B~ is same as [Fig 4h](#F4){ref-type="fig"}. n= 11, 7, 8 cells, from left to right.](nihms-1546056-f0012){#F12}

![Phosphorylation-dependent dissociation of Rad and β~3~ and β~4~ subunits.\
**(a-b)** FRET 2-hybrid binding isotherms were determined for Cerulean (Cer)-tagged β~3~ and β~4~, and N-terminal Venus (Ven)-tagged WT or 4-SA mutant Rad. FRET efficiency (E~D~) is plotted against the free concentration Ven-WT or Ven-4SA-mutant Rad. Solid line fits a 1:1 binding isotherm. Co-expression of the PKA catalytic subunit weakened binding in WT Rad-expressing cells, but not 4-SA mutant Rad-expressing cells. (c) Bar graph summarizing mean K~d,EFF~ for β~2B~, β~3~ and β~4~, and WT and 4-SA mutant Rad, expressed without and with catalytic PKA subunit. Mean ± 95% confidence intervals (CI). The error bars on the K~d,EFF~ are a 95%-CI for the pooled non-linear fits based on the Jacobians computed. The sample size for each condition is 1,580-10,364 cells acquired via two independent transfections and then pooled. The distribution of data in this graph is reflected in [Fig. 4b](#F4){ref-type="fig"}-[c](#F4){ref-type="fig"}, and in (a) and (b) of this figure.](nihms-1546056-f0013){#F13}

![ClustalW alignment of Rad sequences and RGK GTPases.\
**(a)** Conserved phosphorylation sites for mouse Ser^25^, Ser^38^, Ser^272^ and Ser^300^ are shown. Blue highlights basic amino acids (Arg, Lys and His), and red highlights Ser and Thr. **(b)** Phosphorylation sites for mouse Rad Ser^25^, Ser^38^, Ser^272^ and Ser^300^ are indicated (arrows). The C-terminal phosphorylation sites are conserved. The equivalent of Ser^25^ phosphorylation site is conserved in Rem1. The equivalent of Ser^38^ phosphorylation site is probably conserved in Gem. Blue highlights basic amino acids (Arg, Lys and His), and red highlights Ser and Thr.](nihms-1546056-f0014){#F14}
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![Phosphorylation of α~1C~ and β subunits by PKA is not required for β-adrenergic regulation of Ca~V~1.2.\
**(a)**Schematic of rabbit cardiac α~1C~ and β subunits. Red dots indicate putative PKA phosphorylation sites. **(b)** Schematic of binary transgene system. The expression of reverse tetracycline-controlled transactivator (rtTA) is driven by the cardiac-specific α-myosin heavy chain promoter. The cDNAs for FLAG-DHP-resistant (DHP\*) α~1C~ or GFP-β~2B~ were ligated behind 7 tandem *tetO* sequences. **(c)** Exemplar whole-cell Ca~V~1.2 currents of 35-mutant α~1C~ transgenic mice cardiomyocytes in nisoldipine before (black trace) and after isoproterenol (blue trace). Representative of 25 experiments. **(d)** Fold-change of peak DHP-resistant Ca^2+^ current at 0 mV caused by isoproterenol or forskolin. Mean ± SEM. *P* =0.39 by unpaired two-tailed t-test. n= 45 cardiomyocytes from 5 mice, n = 25 cardiomyocytes from 5 mice. **(e-f)** Exemplar whole-cell Ca~V~1.2 currents of GFP-tagged-28-mutant β~2B~ transgenic mice cardiomyocytes, and 35-mutant α~1C~ X 28-mutant β~2B~ transgenic mice cardiomyocytes. Representative of 8 and 22 independent experiments respectively. **(g)** Fold-change in peak Ca^2+^ current caused by isoproterenol or forskolin for cardiomyocytes isolated from transgenic mice expressing GFP-tagged WT β~2B~ subunit ^[@R17]^, GFP-tagged 28-mutant β~2B~, or both 35-mutant α~1C~ and GFP-tagged 28-mutant β~2B~. Mean ± SEM. *P* =0.27 by one way-ANOVA. n= 19, 8, 21 cardiomyocytes from 4, 4, 3 mice, from left to right.](nihms-1546056-f0001){#F1}

![Changes in Ca~V~1.2 subdomain proteome upon β-adrenergic agonist activation of PKA signaling in heart.\
**(a)** Immunofluorescence of isolated α~1C~-APEX2 and β~2B~-APEX2 cardiomyocytes exposed to biotin-phenol and H~2~O~2~. Representative of 13 and 8 cardiomyocytes from 2 and 3 mice respectively. Scale bar = 5 μm. **(b)** Immunofluorescence of tissue sections of Langendorff-perfused α~1C~-APEX2 heart. Scale bars: upper −100 μm; lower − 5 μm; lower inset− 5 μm. Representative of 10 sections from 2 mice. **(c)** Immunoblots of biotin-labeled proteins from α~1C~-APEX2 and β~2B~-APEX2 mice cardiomyocytes. In contrast to Ca~V~1.2 subunits, RyR2, Jph2 and CaM, K~V~1.5 channels were not detected in streptavidin-pulldown. Blots representative of 3 independent experiments. **(d)** Schematic of workflow for isolated cardiomyocytes. **(e)** Volcano plot of fold-change for relative protein quantification by TMT mass spectrometry of α~1C~-APEX2 samples. Data shown are means for 5 pairs of biologically-independent samples. Non-adjusted unpaired two-tailed t-test. Rad (red dot) is reduced by 50% and PKA catalytic subunit (green dot) is increased by 50%. **(f)** Same as (e) except cardiomyocytes from β~2B~-APEX2 mice. Data shown are means for 3 pairs of biologically independent samples. Rad is reduced by 30% and PKA catalytic subunit is increased by 68%. **(g)** Schematic of protein labeling and workflow for Langendorff-perfused α~1C~-APEX2 mice hearts. bpm= beats per minute. **(h)** Same as (d) except proteins from α~1C~-APEX2 whole heart samples. Data shown are means for 10 hearts, 5 without isoproterenol and 5 with isoproterenol. Rad is reduced by 36% **(i)** Schematic of workflow for isolated cardiomyocytes from non-transgenic (NTG) mice. **(j)** Same as (e) except proteins isolated from non-transgenic (NTG) mice cardiomyocytes without biotinylation or pull-down. \* single peptide ESFDSQSLINNQSK. Data shown are means for 4 pairs of biologically-independent samples. Rad (red dot) in whole heart is unchanged by isoproterenol. For source gel data, see [Supplementary Fig. 1](#SD8){ref-type="supplementary-material"}.](nihms-1546056-f0002){#F2}

![Phosphorylation of Rad is required for cAMP-PKA activation of Ca~V~1.2.\
**(a, c, e, f)** Ba^2+^ current elicited by voltage ramp every 10s. Black traces before and blue traces after forskolin. Representative of 15,16, 8 and 13 cells, respectively. **(b, d)** Diary plot of normalized Ba^2+^ current amplitude at 0 mV. Representative of 15 and 16 cells. **(g)** Fold-change in maximum conductance (G~max~) induced by forskolin. Mean ± SEM. *P* \< 0.0001 by one-way ANOVA; \*\* *P* \< 0.01, \*\*\*\* *P* \< 0.0001 by Tukey's test. n= 27, 76, 9, 23, 18 cells, from left to right. Specific *P* values can be found in the Source Data associated with this figure. **(h)** Boltzmann function parameter V~50~. Mean ± SEM. \*\*\* *P* \<0.001 by two-tailed paired t-test. n= 15, 16, 8, 13, from left to right. (**i)** Fold-change in G~max~ induced by forskolin in absence and presence of Rad. Mean ± SEM. \*\*\*\* *P* \< 0.0001 by unpaired two-tailed t-test. n= 7, 16, left to right. **(j-l)** The top rows display stochastic records, where channel closures are zero-current portions of the trace (horizontal gray lines) and openings are downward deflections to the open level (slanted gray lines). Bottom row: pale blue and gray lines are average P~O~-V relationship from multiple cells. Blue and black lines are Boltzmann fits. In all experiments, α~1C~ and β~2B~ were expressed in HEK cells with no Rad (j), WT Rad (k), or 4 SA-mutant Rad (l), in the absence or presence of exogenous PKA catalytic subunit. Dashed line is maximal P~O~ for control of α~1C~ + β~2B~ without Rad. Scale bars: 1 pA and 25 ms. Control, n= 10; Control + PKA, n=5; Rad, n=5; Rad + PKA, n=8; 4SA mutant Rad, n=6, 4SA mutant Rad + PKA, n=5.](nihms-1546056-f0003){#F3}

![RGK GTPases confer adrenergic regulation to Ca~V~1.2, Ca~V~1.3 and Ca~V~2.2 channels via binding to β.\
(**a)** Fold-change in G~max~. Mean ± SEM. *P* \< 0.0001 by one-way ANOVA; \*\*\* *P* \< 0.001 by Dunnett's test. Data for Rad is same as [Fig. 3g](#F3){ref-type="fig"}. n= 76, 20, 15, left to right. Specific *P* values can be found in the Source Data associated with this figure. **(b-c)** FRET efficiency (E~D~) is plotted against the free concentration Ven-WT (b) or Ven-4SA-mutant Rad (c). Solid line fits a 1:1 binding isotherm. **(d)** Ba^2+^ current of Ca~V~1.3 channels without or with expression of Rad elicited by voltage ramp every 10 s. Black traces before and blue traces after forskolin. No Rad, Rad: 7 cells each. **(e)** Fold-change in G~max~. Mean ± SEM. \*\*\*\* P \<0.0001 by unpaired two-tailed t-test. n= 7 for both. **(f)** Boltzmann function parameter V~50~. Mean ± SEM. \* *P* \< 0.05; \*\* *P* \<0.01 by paired two-tailed t-test. n=7 for no Rad and Rad. **(g)** Ba^2+^ current of Ca~V~2.2 channels without or with expression of Rad or Rem elicited by voltage ramp every 10 s. Black traces before and blue traces after forskolin. Representative of 11,11,15, top to bottom. **(h)** Fold-change in G~max~. Mean ± SEM. *P* \< 0.001 by one-way ANOVA; \*\*\*\* *P* \< 0.0001, \*\*\* *P* \<0.001, \* *P* \< 0.05 by Dunnett's test. n= 11, 11, 15, left to right. **(i)** Boltzmann function parameter V~50~. Mean ± SEM. \*\*\*\* *P* \<0.001 by paired two-tailed t-test; n=11, 11, 15, from left to right. **(j-k)** Proposed model of β-adrenergic regulation of Ca^2+^ channels. Basal state (j) and after (k) β-agonist-induced activation of PKA leads to PKA-phosphorylation of Rad causing dissociation of Rad from the Ca~V~1.2 complex and subsequently increased Ca^2+^ influx. AC: adenylyl cyclase.](nihms-1546056-f0004){#F4}
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